Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Market doesn’t look too good? Huh? The dow is 200 points below its 52 week high of 26,966. Which market are you speaking of - which index? Cash drain - from what international fixed income? Not sure what you’re referring to?
I dunno, when I read about research like this that assists in connecting the dots between bone marrow transplant,GvHD, and cure for HIV, I get excited. As long as their PRs are factual, I say keep them coming.
https://www.ohsu.edu/vaccine-gene-therapy-institute/sacha-laboratory
There have been posts requesting a high profile researcher on the HIV side be added to the company. I am excited that someone from this group, https://www.ohsu.edu/people/jonahsacha/afe04ac2cdbb398b117904f0e36a9dbb, is working with us.
https://www.ohsu.edu/vaccine-gene-therapy-institute/sacha-laboratory
There weren’t revenues posted.
A17, I think I would have been right there with you up until the GVHD trial and ph3 pivotal endpoint last year and then we added Dr RP and now we’re surrounding Dr NP with the talent and experience to bring this home. Stop looking in the rear view mirror, we aren’t what we once were.
I’m very sorry for your loss.
How do you know he’s competent? They’re a private firm and he’s been there about a year. He lists himself as director or chairman of a number of biotechs - similar to Fife. Graduate of Univ of Michigan which is an achievement. Not trying to be argumentative, Just trying to understand why he stands out in your opinion. Bloomberg profile has him at many firms, not staying for long at any one spot.
For me marathons are about the months of special diet, sacrifice, long training runs, overcoming injury, two steps back, three steps forward. Learning from others with more knowledge than you. Overcoming obstacles. Passing that goof at mile 13 with you’re almost there sign. That’s why I respect Dr NP. The reading, the learning, knocking on this door and that door, never quitting. You can find plenty of people with the appropriate degrees and knowledge but you can’t teach drive, the will to get this done. Surround him with the right talents, we’ll get there. We’ve come so far.
We have people with HIV living four years on Leronlimab. Four years without any side affects, living a quality life. Someday Soon (another favorite song of mine) we’ll give hope to those with TNBC. In the grand scheme of things this is a blip on the radar. Take a deep breath, but only invest to your comfort level.
I agree completely!
My understanding of why it was shelved was pro-140 became available and was further ahead in testing, saving us funds. In those days we spent our funds on legal fees protecting our patent.
I found this article very interesting as it discusses the need for better planning of clinical tests using CTCs and ctDNA samples. In my mind, this is the phase we are in, planning stage - even the collection tube used for the sample has an impact that can affect the life of the patient. We provided a basic framework of the study, the FDA said yes, we ran additional tests on special mice which produced phenomenal results, went back to the FDA for additional approvals which provide additional insight on test design.
We have Dr NP and Dr RP who just began working together in November. They need to learn how to do this to set appropriate expectations. Take a deep breath and let the scientists do what they do.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024152/
Does the company realize that firms like Fidelity won’t let their clients buy it when they don’t stay on top of their filings? Basic business 101 and the company needs to step up.
Would you merge with someone who can’t keep up with SEC reporting? He needs to get his act together on that front.
I have lived this and there are no truer words.
Did you verify your assumptions by emailing the company?
Thanks for your efforts supporting the share price BobbyI! I appreciate it. I did all I could last week - oh well a bit early.
Still a believer and long.
The stock lending business is what let’s the major wire houses charge 4.95 on commission. Good luck reigning that in.
I’d be happy with an email to interested shareholders.
Thank you!!
Yes and when that happens, Fidelity’s risk department will not let you add to your position. That’s a large number of people not able to buy. As we add to our positions, I want a larger pool to sell to when the time comes not limited. This needs to be someone’s top priority at the firm.
They need to keep track of their SEC requirements or this will blow up in their face. I’m pissed at the moment.
Well, here we go again, they’re not taking care of their filings - can’t buy at Fidelity and OTCMarkets says no info. They need to get it together.
I’m sorry to be dense but what, or whom is ACRA?
Thank you Grip.
Good to hear. I’m in NJ and I’ve been wondering if there’s an appeal to get a pot card if you’re an individual. I saw something about e-wallet on their website and that’s intriguing.
Recent press release from Menarini Silicon Biosystems, the pioneer of liquid biopsy technology, and a quote from Dr. Cristofanilli, regarding upcoming mTNBC study. We're not mentioned by name.
"“This is an exciting study, as it provides evidence of CCR5 being a potential therapeutic target for breast cancer,” said Dr. Cristofanilli. “This observation is the basis of an upcoming clinical trial incorporating detection CCR5/CTC expression and in which we will target CCR5 with a specific antibody in the hopes of preventing metastasis and prolong disease control in patients with TNBC.”
http://www.siliconbiosystems.com/press-releases/new-cellsearch-data-to-be-presented-at-aacr-deepens-understanding-of-metastatic-breast-cancer
I know we’ve got the sale side but I think $PYX and maybe others in Canada have the supply tracking software already built
Dr NP’s passion and knowledge came through loud and clear.
Potential cheaper and faster assay for determining who is potential candidate for mono pivotal - they’re going to run test on participants from investigational trial prior to submitting for mono pivotal. Current test for participation $2k and 4 weeks, new test $400 and 4 hours Plus they’ll have a greater understanding of which dosage they’ll respond to. Target 6-8 weeks.
Good point!
No - I’m not reading anything negative in today’s PR
Anyone have an idea how many clients they have?
Soon for one party has a different connotation for another party. I’m glad they’re requesting this and all the benefits that encompass fast track designation with respect to trial design. Dr Dhody is the contact for the TNBC trial and he was just at CROI.
“FTD facilitates frequent interactions with the FDA review team, including meetings to discuss the product’s development plan and written communications about issues such as trial design and use of biomarkers. “
The toxicity - people stop their cancer treatments because of this, my mother in law did. Quality of life. Dr NP spoke so passionately about that for those in the extension trial during a recent presentation. From that perspective this is a change in current treatment.
I did not. Dr. NP spoke of it in his opening before turning over to Dr. RP, and then again during Q&A - in response to their salary increases and a question from someone who attended Noblecon - asking what field of use those making offers are in. I have meetings I need to prep for and won't be able to listen again until tonight.
It was helpful to me to listen to the call again today.
BLA delayed - the FDA wants a timeline for patients which we're negotiating on - worst case third quarter, best case 2nd quarter. I don't have a scientific brain and am not sure of the details that entails - but worst case 3rd quarter. They'll have 525 and 700 data available at CROI in March
They've received an offer they like for 1/2 billion in manufactured product to be delivered 2nd half 2020 and they're in process of signing this.
They're reviewing licensing deals and they're reviewing them and are preparing reply with their counter offers.
We should expect to see a new powerpoint on their plan for commercialization on the website which is being created by the new business development company, Empire.
We're hiring an employee with responsibility for new business development.
Dr. Pestell said Prognostic Test for Prostate Cancer they're working in collaboration with strategic partner and will be filing a 5 10k to FDA? not sure I heard this correctly - he spoke very softly on this call.
Dr. Pestell discussed the highly cost effective strategy that the FDA has been approving of studying mechanisms for cancer - Mechanism CCR5 is the overarching strategy. This sounds like a big deal that hasn't been discussed by the scientific minds on this board and I'd appreciate it if you could expand on this concept.
Mike / CFO is ready to uplist should the submission for Orphan Drug status in human breast cancer and other positive news on the cancer front sufficiently moves our share price UP.
That’s amazing and best of luck to your pup
You are correct, people here are investors. I didn’t learn about CytoDyn here. I’m offering a different perspective from someone who does use their discretionary funds to support an investment in research which may or may not make a return. I won’t clutter your board with a different perspective but it may pertain to others the company is speaking to. This antibody offers hope and will continue to need to raise funds to develop it and commercialize it. They will sell it through normal channels and I believe they’ll distribute it to those in need with less means. I recall Dr RP saying something to that effect when he first came here.
A clinical biotech requesting funds only from an accredited investor is a chance for the investor to be a part of saving lives. That this is on a penny stock chat board is the disconnect. There is no guarantee and if you can’t afford to wait or even loose your money then you should be invested elsewhere.
They’re trying a new communication tool and Dr RP was informative, Dr NP sounded rushed. He’ll work on his delivery with this new format, if they keep it. I suppose because of my life experiences I’m focused on the hope brought by Dr Pestell. I’ve been here a while and we’ve always been able to raise funds. As long as there’s hope, they’ll get my money. Here’s hoping you don’t have to tell your young children you have cancer or hear from a loved one that they’ve decided to stop their treatment as they can’t tolerate it any longer. We have people who are living four years on this drug ! There’s great hope here.